Skip to main content

Table 2 Univariable logistic regression analysis for the prediction of ISR

From: Impact of anemia on in-stent restenosis after percutaneous coronary intervention

Variable

OR

95% CI

P value

Gender

0.708

0.319–1.571

0.396

Age

1.003

0.967–1.042

0.858

Current smoker

1.020

0.473–2.199

0.961

BMI

0.908

0.788–1.046

0.179

Hypertension

1.186

0.544–2.587

0.668

Diabetes mellitus

2.588

1.176–5.696

0.018

LDL-c

1.651

1.187–2.296

0.003

TG

0.813

0.489–1.353

0.426

LVEF

0.958

0.916–1.001

0.057

Anemia

4.283

1.949–9.410

< 0.001

CKD

3.058

1.289–7.252

0.011

ACS

0.948

0.442–2.033

0.890

Multiple stenting

2.592

1.205–5.573

0.015

Stent length (mm)

0.974

0.908–1.044

0.456

Stent diameter (mm)

3.413

1.361–8.547

0.009

Multivessel coronary disease

1.176

0.464–2.980

0.732

LMCA

3.846

0.801–18.460

0.092

LAD

1.933

0.794–4.707

0.146

LCX

2.191

0.992–4.840

0.052

RCA

0.508

0.212–1.218

0.129

Bifurcation lesion

2.669

1.236–5.763

0.012

Calcification

3.529

1.131–11.014

0.030

Statins

0.727

0.164–3.223

0.674

Aspirin

NA

NA

NA

Clopidogrel

0.853

0.397–1.828

0.683

Ticagrelor

0.693

0.314–1.530

0.364

  1. ISR In-stent restenosis; BMI body mass index; CKD chronic kidney disease; LVEF left ventricular ejection fraction; ACS acute coronary syndrome; LDL-c low-density lipoprotein cholesterol; TG triglycerides; LMCA left main conronary artery; LAD left anterior descending artery; LCX left circumflex artey; RCA right coronary artery